Cytogenetic evaluation of patients in relation to the use of oral contraception.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002842:Chromatids / Q000187:drug effects; D002869:Chromosome Aberrations / Q000139:chemically induced*; D025063:Chromosome Disorders; D003276:Contraceptives, Oral / Q000009:adverse effects* / Q000494:pharmacology; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007223:Infant; D008214:Lymphocytes / Q000187:drug effects; D008234:Lynestrenol / Q000494:pharmacology; D008297:Male; D008525:Medroxyprogesterone / Q000494:pharmacology; D008875:Middle Aged; D013997:Time Factors; D014178:Translocation, Genetic
D003276:Contraceptives, Oral; D004338:Drug Combinations; D008525:Medroxyprogesterone; D008234:Lynestrenol